Recurrence risk after sentinel lymph node biopsy in patients with early cervical cancer: Follow-up results after 3 years of a prospective study (SENTICOL)
Recurrence risk after sentinel lymph node biopsy in patients with early cervical cancer: Follow-up results after 3 years of a prospective study (SENTICOL)